Hydrocephalus Shunts Market To Reach $599.42 Million By 2030

Hydrocephalus Shunts Market Growth & Trends

The global hydrocephalus shunts market size is anticipated to reach USD 599.42 million by 2030, registering at a CAGR of 3.99% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing public and private funding for neurological disorders treatments, increasing clinical studies for the product development, and the rise in regulatory approval for product launch are key contributors to the market growth.

The industry key players are also involved in developing devices for the treatment of hydrocephalus and other neurological disorders. The increasing clinical studies for the product portfolio development further drives the growth of the market. For instance, in October 2023, as part of the ongoing clinical trials evaluating the effectiveness of the device for the treatment of communicating hydrocephalus, CereVasc, Inc. revealed that a milestone 30^th patient received the eShunt Implant. The first of these pilot studies, which was carried out in Argentina under regulatory approval from the National Administration of Drugs, Food and Medical Devices (ANMAT), and the second was executed in the U.S. under FDA approval for an Investigational Device Exemption (IDE) to study a minimally invasive treatment for communicating hydrocephalus. Thus, due to such positive outcomes from the clinical studies will drive the market growth in near future.

 Request a free sample copy or view report summary: Hydrocephalus Shunts Market Report

Hydrocephalus Shunts Market Report Highlights

• Based on product, valves segment dominated the market in 2023 with a share of 71.26%. Adjustable valves empower healthcare professionals to customize settings according to the patient's specific needs, thereby optimizing the treatment process.

• The hospitals segment held 75.87% of the overall end user market in 2023. Increasing number of patients being admitted to hospitals due to surgeries, therapies, and treatments is expected to increase the demand for hydrocephalus shunts in near future.

• North America dominated the overall regional market with the highest revenue share of 37.97% in 2023 owing to high incidence rate of neurological disease & hydrocephalus in this region.

• Key players in hydrocephalus shunts market include Medtronic, Aesculap, Inc., Spiegelberg GmbH & Co. KG., Integra LifeSciences, Sophysa, CHRISTOPH MIETHKE GMBH & CO. KG, Hpbio, G. Surgiwear Ltd, and Bicakcilar.

Hydrocephalus Shunts Market Segmentation

Grand View Research has segmented the global hydrocephalus shunts market on the basis of product, end-use, and region:

Hydrocephalus Shunts Product Outlook (Revenue, USD Million, 2018 - 2030)

• Valves

• Catheters                                                                                           

Hydrocephalus Shunts End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Ambulatory Surgical Centers

Hydrocephalus Shunts Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Norway

  • Sweden

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Mexico

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Hydrocephalus Shunts Market

• Medtronic

• Aesculap, Inc.

• Spiegelberg GmbH & Co. KG.

• Integra LifeSciences

• Sophysa

• CHRISTOPH MIETHKE GMBH & CO. KG

• Hpbio

• G. Surgiwear Ltd

• Bicakcilar